( OTC-PINK:PBIO )

News from pressure biosciences, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 18, 2016, 12:33 ET Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the 2016 first quarter ended March 31,...


May 17, 2016, 13:23 ET Pressure BioSciences, Inc. to Discuss First Quarter 2016 Financial Results and Provide Business Update

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First...


Apr 12, 2016, 12:18 ET Pressure BioSciences Added to the High-Performing Richmond Club Index; Richmond Index Has Outperformed the S&P 500 Index by an Average of 11% Each Year for the Past Ten Years

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling pressure cycling...


Apr 07, 2016, 11:05 ET Pressure BioSciences Closes Additional $769K in PIPE Financing; Final Close Brings Total Raised to Over $6.3 Million, Substantially Above Company's Goal of $5 Million

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Apr 06, 2016, 10:46 ET Pressure BioSciences, Inc. Reports Fiscal Year 2015 Financial Results and Provides Business Update

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the fiscal year ended December 31,...


Mar 14, 2016, 09:17 ET Pressure BioSciences to Participate in SCIEX Workshop on New Innovations Towards Industrialized Proteomics at US HUPO Conference

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling pressure cycling...


Mar 01, 2016, 10:18 ET Pressure BioSciences Closes $550,000 First Tranche of $5 Million PIPE Over-Subscription Amount

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Jan 11, 2016, 10:43 ET Pressure BioSciences Exceeds $5 Million PIPE Goal and Opens $1.25 Million Over-Subscription Amount

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Dec 15, 2015, 08:51 ET Pressure BioSciences Eliminates All Remaining Variable Rate (Floorless) Convertible Notes

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Nov 17, 2015, 10:16 ET Pressure BioSciences Closes Additional $745,000 of $5 Million PIPE; Funding Received to Date Exceeds $4,000,000

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Nov 16, 2015, 16:06 ET Pressure BioSciences, Inc. Reports Record Third Quarter and Year-to-Date 2015 Financial Results and Provides Business Update

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Nov 16, 2015, 15:06 ET Pressure BioSciences, Inc. to Discuss Third Quarter 2015 Financial Results and Provide Business Update

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its...


Nov 12, 2015, 10:51 ET Pressure BioSciences, Inc. Reports Record Third Quarter and Year-to-Date 2015 Financial Results and Provides Business Update

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Oct 16, 2015, 08:44 ET Pressure BioSciences and Florida International University Enter Into Formal Agreement to Develop an Improved Rape Kit Test Method Based on PBI's Patented PCT Platform

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Sep 28, 2015, 11:07 ET Pressure BioSciences Closes Additional $1,100,000 of $5 Million PIPE; Total Funds Received to Date Reach $3,280,000

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Sep 01, 2015, 09:13 ET New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Aug 26, 2015, 07:50 ET Pressure BioSciences and the Institute of Bioinformatics Announce Comprehensive Two Year Collaboration

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling pressure cycling...


Aug 17, 2015, 09:18 ET Pressure BioSciences, Inc. Reports Second Quarter and Year-to-Date 2015 Financial Results and Provides Business Update

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three and six-month periods ended...


Aug 14, 2015, 09:00 ET Pressure BioSciences, Inc. to Discuss Second Quarter 2015 Financial Results and Provide Business Update

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its...


Jul 23, 2015, 09:21 ET Pressure BioSciences Closes $2,180,000 Initial Tranche of a $5 Million Private Placement

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Jul 15, 2015, 09:23 ET Pressure BioSciences' PCT Platform a Key Workflow Component in Study to Discover Potential Biomarkers and Underlying Pathways in the Emergence and Progression of COPD-Associated Lung Cancer

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure...


Jul 13, 2015, 09:35 ET Suggested Workflow to Accelerate the Discovery of New Biomarkers for Early Diagnosis and Prediction of Complications in Diabetes Includes Pressure BioSciences' Novel PCT Platform

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Jul 07, 2015, 08:16 ET Pressure BioSciences' PCT Platform Results in a Promising New Method for Improved Extraction of DNA from Rape Kits and other Forensic Samples

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling...


Jun 29, 2015, 09:32 ET Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure...


Jun 15, 2015, 11:57 ET Pressure BioSciences Selected by NIH to Exhibit and Showcase its PCT Technology Platform in the High Profile Innovation Zone at the 2015 BIO International Convention

 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a worldwide leader in the development and sale of high pressure-based...